- Home
- ONFO vs XBIO Comparison
ONFO vs XBIO Comparison
Compare ONFO & XBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONFO
- XBIO
- Stock Information
- Founded
- ONFO 2018
- XBIO N/A
- Country
- ONFO United States
- XBIO United States
- Employees
- ONFO N/A
- XBIO N/A
- Industry
- ONFO Computer Software: Programming Data Processing
- XBIO Biotechnology: Pharmaceutical Preparations
- Sector
- ONFO Technology
- XBIO Health Care
- Exchange
- ONFO Nasdaq
- XBIO Nasdaq
- Market Cap
- ONFO 5.0M
- XBIO 4.4M
- IPO Year
- ONFO 2022
- XBIO N/A
- Fundamental
- Price
- ONFO $1.16
- XBIO $2.69
- Analyst Decision
- ONFO
- XBIO Hold
- Analyst Count
- ONFO 0
- XBIO 1
- Target Price
- ONFO N/A
- XBIO N/A
- AVG Volume (30 Days)
- ONFO 66.9K
- XBIO 165.9K
- Earning Date
- ONFO 11-14-2025
- XBIO 11-10-2025
- Dividend Yield
- ONFO N/A
- XBIO N/A
- EPS Growth
- ONFO N/A
- XBIO N/A
- EPS
- ONFO N/A
- XBIO N/A
- Revenue
- ONFO $10,508,728.00
- XBIO $2,446,221.00
- Revenue This Year
- ONFO N/A
- XBIO $1.99
- Revenue Next Year
- ONFO N/A
- XBIO $20.00
- P/E Ratio
- ONFO N/A
- XBIO N/A
- Revenue Growth
- ONFO 78.36
- XBIO N/A
- 52 Week Low
- ONFO $0.61
- XBIO $2.20
- 52 Week High
- ONFO $1.95
- XBIO $13.93
- Technical
- Relative Strength Index (RSI)
- ONFO 54.84
- XBIO 38.21
- Support Level
- ONFO $1.04
- XBIO $3.56
- Resistance Level
- ONFO $1.26
- XBIO $3.45
- Average True Range (ATR)
- ONFO 0.07
- XBIO 0.28
- MACD
- ONFO 0.01
- XBIO -0.20
- Stochastic Oscillator
- ONFO 62.30
- XBIO 1.60
About ONFO Onfolio Holdings Inc.
Onfolio Holdings Inc actively manages small online businesses that operate in sectors with long-term growth opportunities, have positive and stable cash flows, face minimal threats of technological or competitive obsolescence, and can be managed by existing teams or have management teams largely in place. The company operates in two business segments: Business to Business (B2B) and Business to Consumers (B2C). The majority of its revenue is generated from the Business-to-Business (B2B) segment, which includes the results of operations of Eastern Standard, RevenueZen, DDS Rank, SEO Butler, Contentellect, DealPipe, and Onfolio LLC.
About XBIO Xenetic Biosciences Inc.
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.